The emerging treatment of this peptide represents a significant development in the care of the condition. Different to existing medications, tirzepatide targets dual pathways – the GLP-1 hormone and the GIP hormone – resulting in greater sugar regulation and anticipated weight reduction. Experts are investigating its potential advantages and pl